Anavex Life Sciences logo

AVXL Anavex Life Sciences

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Healthcare Biotechnology SIC: Unknown CIK: 1314052 Auditor raised Adverse Opinion

Login to follow AVXL

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating